![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Edwards Joanne
Publisher: Informa Healthcare
ISSN: 1354-3784
Source: Expert Opinion on Investigational Drugs, Vol.19, Iss.5, 2010-05, pp. : 605-614
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Src inhibitors: drugs for the treatment of osteoporosis, cancer or both?
By Susva M. Missbach M. Green J.
Trends in Pharmacological Sciences, Vol. 21, Iss. 12, 2000-12 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Emerging tyrosine kinase inhibitors for esophageal cancer
By Ku Geoffrey Y Ilson David H
Expert Opinion on Emerging Drugs, Vol. 18, Iss. 2, 2013-06 ,pp. :